The role of Th17 cells in the pathogenesis and treatment of breast cancer

V Karpisheh, M Ahmadi, K Abbaszadeh-Goudarzi… - Cancer Cell …, 2022 - Springer
Breast cancer is a severe problem worldwide due to an increase in mortality and prevalence
among women. Despite early diagnostic procedures as well as advanced therapies, more …

Role of immune cells and receptors in cancer treatment: an immunotherapeutic approach

AG Mukherjee, UR Wanjari, A Namachivayam… - Vaccines, 2022 - mdpi.com
Cancer immunotherapy moderates the immune system's ability to fight cancer. Due to its
extreme complexity, scientists are working to put together all the puzzle pieces to get a …

CCL5 mediates breast cancer metastasis and prognosis through CCR5/Treg cells

J Qiu, L Xu, X Zeng, H Wu, F Liang, Q Lv, Z Du - Frontiers in Oncology, 2022 - frontiersin.org
Background and aims CCL5 is considered to contribute to the biological function of a variety
of cancer types, but its specific mechanism is still unclear. This study aimed to reveal the …

The immunotherapy and immunosuppressive signaling in therapy-resistant prostate cancer

P Xu, LJ Wasielewski, JC Yang, D Cai, CP Evans… - Biomedicines, 2022 - mdpi.com
Prostate cancer is one of the most common malignant tumors in men. Initially, it is androgen-
dependent, but it eventually develops into castration-resistant prostate cancer (CRPC) …

Phytochemicals as immunomodulatory molecules in cancer therapeutics

S Paudel, N Mishra, R Agarwal - Pharmaceuticals, 2023 - mdpi.com
Phytochemicals are natural plant-derived products that provide significant nutrition, essential
biomolecules, and flavor as part of our diet. They have long been known to confer protection …

Different T cell related immunological profiles in COVID-19 patients compared to healthy controls

AMS Khesht, V Karpisheh, BQ Saeed, AO Zekiy… - International …, 2021 - Elsevier
In various pathological conditions, cellular immunity plays an important role in immune
responses. Among immune cells, T lymphocytes pdomote cellular and humoral responses …

Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells …

AMS Khesht, V Karpisheh, PS Gilan… - International journal of …, 2021 - Elsevier
Chemotherapy drugs are still one of the first treatment options used in many cancers;
however, problems such as cytotoxic side effects on normal cells after systemic …

Immunotherapy in prostate cancer: state of art and new therapeutic perspectives

FM Maselli, F Giuliani, C Laface, M Perrone… - Current …, 2023 - mdpi.com
Prostate cancer (PC) is the most common type of tumor in men. In the early stage of the
disease, it is sensitive to androgen deprivation therapy. In patients with metastatic castration …

ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis

Y Lin, Y Zhang, Z Tuo, L Gao, D Ding, L Bi, D Yu, Z Lv… - BMC cancer, 2023 - Springer
Background The origin recognition complex (ORC), a six-subunit DNA-binding complex,
participates in DNA replication in cancer cells. Specifically in prostate cancers, ORC …

[HTML][HTML] Advances in landscape and related therapeutic targets of the prostate tumor microenvironment: Therapeutic targets of the prostate tumor microenvironment

D Li, W Xu, Y Chang, Y Xiao, Y He… - Acta Biochimica et …, 2023 - ncbi.nlm.nih.gov
The distinct tumor microenvironment (TME) of prostate cancer (PCa), which promotes tumor
proliferation and progression, consists of various stromal cells, immune cells, and a dense …